Surrozen Says FDA Cleared IND For SZN-8141 In Diabetic Macular Edema, Triggering About $95.1M Second Tranche Of Private Placement

Loading news article.

Surrozen Says FDA Cleared IND For SZN-8141 In Diabetic Macular Edema, Triggering About $95.1M Second Tranche Of Private Placement | WAPE

Article summary